Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Novick

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
Acta Psychiatrica Scandinavica|February 11, 2005
Olanzapine vs. other antipsychotics in actual out-patient settings: six months tolerability results from the European Schizophrenia Out-patient Health Outcomes studyM Lambert, J M Haro, D Novick, et al.
Pharmacopsychiatry|July 9, 2009
Translation of randomised controlled trial findings into clinical practice: comparison of olanzapine and valproate in the EMBLEM studyD Novick, A Gonzalez-Pinto, J M Haro, et al.
Annals of the New York Academy of Sciences|January 1, 1989
Biological activities of recombinant human IFN-beta 2/IL-6 (E. coli)M Revel, A Zilberstein, L Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 3, 2000
Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18S H Kim, M Eisenstein, L Reznikov, et al.
Journal of Interferon Research|December 1, 1992
Expression of active human interferon-beta in transgenic plantsO Edelbaum, D Stein, N Holland, et al.
Biochemistry|April 22, 2026
Profiling Selectivity for the <i>Shigella</i> Virulence Factor OspFNicholas P McCurtin, Ariana Gazaferi, Noah D Novick, et al.
Blood|April 15, 1993
Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-alpha or -betaD Aderka, Y Maor, D Novick, et al.
Pharmacopsychiatry|January 19, 2008
Determinants of voluntary vs. involuntary admission in bipolar disorder and the impact of adherenceD Schuepbach, D Novick, J M Haro, et al.
Pharmacopsychiatry|May 7, 2010
The number needed to treat for all-cause medication discontinuation in the treatment of schizophrenia: consistency across world geographies and study designsD Novick, H Ascher-Svanum, B Zhu, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1991
Differential signal transduction via T-cell receptor CD3 zeta 2, CD3 zeta-eta, and CD3 eta 2 isoformsA Bauer, D J McConkey, F D Howard, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
Acta Psychiatrica Scandinavica|February 11, 2005
Olanzapine vs. other antipsychotics in actual out-patient settings: six months tolerability results from the European Schizophrenia Out-patient Health Outcomes studyM Lambert, J M Haro, D Novick, et al.
Pharmacopsychiatry|July 9, 2009
Translation of randomised controlled trial findings into clinical practice: comparison of olanzapine and valproate in the EMBLEM studyD Novick, A Gonzalez-Pinto, J M Haro, et al.
Annals of the New York Academy of Sciences|January 1, 1989
Biological activities of recombinant human IFN-beta 2/IL-6 (E. coli)M Revel, A Zilberstein, L Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 3, 2000
Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18S H Kim, M Eisenstein, L Reznikov, et al.
Journal of Interferon Research|December 1, 1992
Expression of active human interferon-beta in transgenic plantsO Edelbaum, D Stein, N Holland, et al.
Biochemistry|April 22, 2026
Profiling Selectivity for the <i>Shigella</i> Virulence Factor OspFNicholas P McCurtin, Ariana Gazaferi, Noah D Novick, et al.
Blood|April 15, 1993
Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-alpha or -betaD Aderka, Y Maor, D Novick, et al.
Pharmacopsychiatry|January 19, 2008
Determinants of voluntary vs. involuntary admission in bipolar disorder and the impact of adherenceD Schuepbach, D Novick, J M Haro, et al.
Pharmacopsychiatry|May 7, 2010
The number needed to treat for all-cause medication discontinuation in the treatment of schizophrenia: consistency across world geographies and study designsD Novick, H Ascher-Svanum, B Zhu, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1991
Differential signal transduction via T-cell receptor CD3 zeta 2, CD3 zeta-eta, and CD3 eta 2 isoformsA Bauer, D J McConkey, F D Howard, et al.
Pageof 11